I have to agree with your comment about revenue. I took a hit...

I have to agree with your comment about revenue. I took a hit and sold out on Tuesday as could not see a decent revenue stream for at least 1 year++

1. Too much competition in the MM sector IMO.

2.gel pel is overpriced and I think you'll find sales may be struggling due to this.

3. Clinical trials will suck up funds like a vacuum.

Rec side has the most potential but probably better off just investing in hvst like some of the smart ones here have done. If can get some hvst in the 50's would be a good long play until revenue starts flowing in.

GLTAH.